[1] Choudhry NK. Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes[J].JAMA Int Med,2018,178(9):1182-1185. [2] 陈慧敏,许逸飞. 苯磺酸氨氯地平联合阿托伐他汀钙治疗老年高血压伴血脂异常的临床研究[J].中国临床药理学杂志,2016,32(12):1072-1074. [3] 陈凯立,张汉洪,邢金莉. 瑞舒伐他汀与阿托伐他汀对急性脑梗死患者血脂CRP及颈动脉粥样硬化斑块的影响比较[J].中国实用神经疾病杂志,2016,19(24):33-35. [4] 刘力生. 中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. [5] 中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J].中华心血管病杂志,2016,44(10):833-853. [6] Yilmaz B, Vellanki P, Ata B,et al.Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis[J].Fertility Sterility,2018,109(2):356-364. [7] Hasanpour Z, Javanmard S, Gharaaty M, et al. Association between serum myeloperoxidase levels and coronary artery disease in patients without diabetes, hypertension, obesity, and hyperlipidemia[J].Adv Biomed Res,2016,5(1):103. [8] 杨焱. 不同剂量阿托伐他汀对老年血脂正常冠心病患者炎症、心功能及心血管事件的影响[J].中国老年学杂志,2016,36(17):4208-4210. [9] 徐艳慧. 探讨瑞舒伐他汀对冠心病患者心功能、血脂水平、血液流变学水平的影响[J].中华临床医师杂志(电子版),2016,10(7):99-100.
2019, Vol. 36 
